O Strahl1, A Hartmann2, F C Thiel1, M W Beckmann3, M P Lux1. 1. FK-Erlangen, Erlangen. 2. Institute of Pathology, Friedrich-Alexander-Universitaet, Erlangen ; Comprehensive Cancer Center Erlangen-Nürnberg. 3. FK-Erlangen, Erlangen ; Comprehensive Cancer Center Erlangen-Nürnberg.
Abstract
Background: We report a case of an 18-year-old woman with an embryonal rhabdomyosarcoma in statu nascendi. Case: A fist-sized embryonal rhabdomyosarcoma of the uterus filling the vaginal vault was diagnosed in an adolescent with virgo intacta suffering from therapy resistant vaginal discharge, bleeding and bulging mass for six months. Further imaging revealed one suspicious pelvine lymph node. Excision of the tumour including the intracervical stalk was performed and followed by systemic multiagent chemotherapy. PET-CT scan presented a complete response after the third cycle. Histological complete response was shown by laparoscopic dissection of regional pelvic lymph nodes and curettage. Conclusion: Uterine Rhabdomyosarcoma should be considered as differential diagnosis of therapy resistant vaginal flour and bleeding in young women. Fertility-sparing therapy is possible in selected exceptional cases.
Background: We report a case of an 18-year-old woman with an embryonal rhabdomyosarcoma in statu nascendi. Case: A fist-sized embryonal rhabdomyosarcoma of the uterus filling the vaginal vault was diagnosed in an adolescent with virgo intacta suffering from therapy resistant vaginal discharge, bleeding and bulging mass for six months. Further imaging revealed one suspicious pelvine lymph node. Excision of the tumour including the intracervical stalk was performed and followed by systemic multiagent chemotherapy. PET-CT scan presented a complete response after the third cycle. Histological complete response was shown by laparoscopic dissection of regional pelvic lymph nodes and curettage. Conclusion: Uterine Rhabdomyosarcoma should be considered as differential diagnosis of therapy resistant vaginal flour and bleeding in young women. Fertility-sparing therapy is possible in selected exceptional cases.
Authors: H Zeisler; K Mayerhofer; E A Joura; D Bancher-Todesca; C Kainz; G Breitenecker; A Reinthaller Journal: Gynecol Oncol Date: 1998-04 Impact factor: 5.482
Authors: S S Donaldson; J Meza; J C Breneman; W M Crist; F Laurie; S J Qualman; M Wharam Journal: Int J Radiat Oncol Biol Phys Date: 2001-11-01 Impact factor: 7.038
Authors: Sarah E Ferguson; William Gerald; Richard R Barakat; Dennis S Chi; Robert A Soslow Journal: Am J Surg Pathol Date: 2007-03 Impact factor: 6.394
Authors: Mark L Kayton; Leonard H Wexler; Sharyn N Lewin; Kay J Park; Michael P La Quaglia; Nadeem R Abu-Rustum Journal: J Pediatr Surg Date: 2009-04 Impact factor: 2.545